Macrogenics (MGNX) Preferred Shares (2012 - 2013)
Macrogenics (MGNX) posted quarterly Preferred Shares of $714012.0 for Q3 2013, up 394.26% quarter-over-quarter from $144462.0 in Q4 2012.
Macrogenics (MGNX) Preferred Shares (2012 - 2013) Analysis & Trends
Macrogenics (MGNX) has reported Preferred Shares for 2 consecutive years, with $714012.0 the latest figure, recorded in Q3 2013.
- In Q3 2013, Preferred Shares changed N/A year-over-year to $714012.0; the TTM figure through Sep 2013 stood at $714012.0 (changed N/A YoY), while the FY2012 annual figure was $144462.0, changed N/A from the prior year.
- Preferred Shares grew to $714012.0 in Q3 2013 per MGNX's latest filing, from $144462.0 in the prior quarter.
- Across five years, Preferred Shares topped out at $714012.0 in Q3 2013 and bottomed at $144462.0 in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Macrogenics | 268.22 Mn | 201.71 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | 714,012.00 |
| Dec 31, 2012 | 144,462.00 |